Characteristic | Total n (%) | 3-year | 3-year | ||
---|---|---|---|---|---|
DFS | P | OS | P | ||
Gender | |||||
Male | 111 (64.2) | 58.4% | 66.1% | ||
Female | 67 (37.6) | 57.0% | 0.640 | 64.7% | 0.366 |
Lymph node metastasis | |||||
(+) | 21 (11.2) | 33.4% | 55.8% | ||
(−) | 166 (88.8) | 59.4% | 0.033 | 67.8% | 0.130 |
Distant metastasis | |||||
(+) | 24 (12.8) | 34.4% | 35.3% | ||
(−) | 163 (87.2) | 60.9% | 0.030 | 70.3% | 0.014 |
Stage | |||||
A | 23 (12.5) | 74.5% | 91.3% | ||
B | 48 (26.1) | 76.1% | 91.2% | ||
C | 113 (61.4) | 45.0% | 0.000 | 49.5% | 0.000 |
Treatment | |||||
Surgery | |||||
Yes | 148 (79.1) | 58.9% | 72.0% | ||
No | 39 (20.9) | 47.4% | 0.038 | 45.7% | 0.000 |
Extent of resection | |||||
Gross total | 106 (77.4) | 72.5% | 90.1% | ||
Subtotal | 31 (22.6) | 31.4% | 0.000 | 46.8% | 0.000 |
RT | |||||
Yes | 153 (81.8) | 65.4% | 70.8% | ||
No | 34 (18.2) | 22.7% | 0.000 | 49.1% | 0.021 |
CT | |||||
Yes | 37 (19.8) | 67.4% | 69.1% | ||
No | 150 (80.2) | 54.3% | 0.162 | 66.0% | 0.472 |
S + RT ± CT | |||||
Yes | 117 (62.6) | 69.0% | 77.1% | ||
No | 70 (37.4) | 37.1% | 0.000 | 49.8% | 0.000 |
S + RT | |||||
Yes | 88 (47.1) | 66.5% | 76.0% | ||
No | 99 (52.9) | 47.8% | 0.019 | 57.9% | 0.011 |
S + RT ± CT | |||||
S + RT | 88 (75.2) | 66.5% | 76.0% | ||
S + RT + CT | 29 (24.8) | 75.3% | 0.283 | 80.6% | 0.589 |
Recurrence | |||||
Yes | 62 (33.2) | 14.1% | 41.0% | ||
No | 125 (66.8) | 81.6% | 0.000 | 82.8% | 0.000 |